Keep Me Logged In
Charley Grant, Wall Street Journal, joins 'The Exchange' to discuss the fall of Biogen's stock after the company announced it would end trials for its experimental Alzheimer's drug.
Got a confidential news tip? We want to hear from you.
Sign up for free newsletters and get more CNBC delivered to your inbox
© 2019 CNBC LLC. All Rights Reserved. A Division of NBCUniversal
Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.
Data also provided by